Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

Mohsen Khademi, Ingrid Kockum, Magnus L Andersson, Ellen Iacobaeus, Lou Brundin, Finn Sellebjerg, Jan Hillert, Fredrik Piehl, Tomas Olsson

209 Citationer (Scopus)

Abstract

Levels of CXCL13, a potent B-cell chemoattractant, are elevated in the cerebrospinal fluid (CSF) during multiple sclerosis (MS) and are associated with markers of MS activity. Levels decrease upon effective treatments.
OriginalsprogEngelsk
TidsskriftMultiple Sclerosis
Vol/bind17
Udgave nummer3
Sider (fra-til)335-43
Antal sider9
ISSN1352-4585
DOI
StatusUdgivet - 2011

Fingeraftryk

Dyk ned i forskningsemnerne om 'Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course'. Sammen danner de et unikt fingeraftryk.

Citationsformater